Intellectual Property


Arbutus Biopharma Seeks a Share of Moderna’s Revenues Should its COVID-19 Vaccine (mRNA-1273) be Approved: Patent Dispute

Moderna, the maker of mRNA-1273, one of the leading COVID-19 experimental vaccine candidates, has attracted enormous attention from investors, society, and the press, not to mention from health authorities and governments around the world. Now they have new attention:...

Hacking Group Launches Successful Ransomware Attacks against UCSF: Experts Think COVID-19 Connection

A notorious hacking group known to target healthcare providers executed what has reported to be a successful ransomware attack this week on the University of California, San Francisco (UCSF). Targeted as an “illegal intrusion” UCSF personnel confirmed the attack but...

Pin It on Pinterest